Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PR Advice To PhRMA: More Communication And Communicate With Moore

Executive Summary

The pharmaceutical industry should cooperate with documentary film maker Michael Moore, talk show host Larry King recommended during the Pharmaceutical Research & Manufacturers of America annual meeting March 18 in Washington, D.C

You may also be interested in...



Symlin And How To Market On Montel Williams

During the PhRMA annual meeting March 18, Amylin CEO Ginger Graham took talk show host Montel William's advice to be proactive in working with him: she volunteered to come on his program, "The Montel Williams Show," to talk about the diabetes agent Symlin (pramlintide), which was approved by FDA two days earlier. In the following exchange, transcribed by "The Pink Sheet," Graham and Williams discuss ways to present a balanced message about a new drug. As of March 22, Amylin said it had not yet made any firm plans with Williams to do a program.

“The New PhRMA:” Education, Communication Are Cornerstones, Tauzin Says

The Pharmaceutical Research & Manufacturers of America will become a resource to support communications efforts by member companies as part of an expanded mission, PhRMA CEO Billy Tauzin told the trade association March 18 in Washington, D.C

“The New PhRMA:” Education, Communication Are Cornerstones, Tauzin Says

The Pharmaceutical Research & Manufacturers of America will become a resource to support communications efforts by member companies as part of an expanded mission, PhRMA CEO Billy Tauzin told the trade association March 18 in Washington, D.C

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045577

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel